CTLA4 Antikörper (FITC)
Kurzübersicht für CTLA4 Antikörper (FITC) (ABIN2740167)
Target
Alle CTLA4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- Antibody ANC152.2/8H5 reacts with an extracellular epitope of human CTLA-4 expressed on activated T cells.
-
Aufreinigung
- Protein A purified
-
Immunogen
-
Mouse IgG1, kappa.
Type of Immunogen: Purified protein -
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
-
Approved: Block, ELISA, Flo
Usage: Anti-CD152/FITC was tested for binding to CD152-muIg-coated 4u beads in FACS (Inquire). Two x 105 CD152-muIg coated beads per tube were spun down and incubated 45 minutes at 4oC with 80 μL of anti-CD152/FITC at a 1:50 dilution (10 μg/mL). Tubes were washed twice, fixed and analyzed by FACS. Beads stained positive with a mean shift of 2.03 log10 fluorescent units when compared to a Mouse IgG1/FITC Isotype control at a similar concentration. Binding was blocked when beads were pre incubated 10 minutes with 20 μL of 0.5 mg/mL anti-CD152 antibody. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 50 mM sodium phosphate, pH 7.5, 100 mM potassium chloride, 150 mM sodium chloride, 0.2 % BSA, 0.04 % sodium azide, 5 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- avoid freeze thaw cycles
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 4°C. Avoid freeze-thaw cycles and prolonged exposure to light.
-
-
- CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))
-
Andere Bezeichnung
- CTLA4 / CD152
-
Hintergrund
-
Name/Gene ID: CTLA4
Synonyms: CTLA4, CD152, CELIAC3, CD152 antigen, CTLA-4, Celiac disease 3, IDDM12, GRD4, GSE, CD152 isoform -
Gen-ID
- 1493
-
Pathways
- Cancer Immune Checkpoints
Target
-